Indivior PLC

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 35.25 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 4.16B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company’s core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; and SUBOXONE Film, a buprenorphine and naloxone sublingual film. It also manufactures SUBOXONE Tablet...